Premium
P4–406: Safety & tolerability of memantine slow titration used in combination therapy with acetylcholinesterase inhibitor medications or as mono–therapy in the treatment of patients with vascular dementia and Alzheimer's disease. The caregiver's impression
Author(s) -
Shua-Haim Joshua R.,
Smith Juanita M.,
Patel Suhas R.,
Forman Evgenia
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.2148
Subject(s) - tolerability , memantine , medicine , dementia , adverse effect , vascular dementia , acetylcholinesterase inhibitor , donepezil , acetylcholinesterase , anesthesia , disease , biochemistry , chemistry , enzyme